Centrosomes are required for proper β-catenin processing and Wnt response.


Journal

Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390

Informations de publication

Date de publication:
01 08 2020
Historique:
pubmed: 26 6 2020
medline: 8 6 2021
entrez: 26 6 2020
Statut: ppublish

Résumé

The Wnt/β-catenin signaling pathway is central to metazoan development and routinely dysregulated in cancer. Wnt/β-catenin signaling initiates transcriptional reprogramming upon stabilization of the transcription factor β-catenin, which is otherwise posttranslationally processed by a destruction complex and degraded by the proteasome. Since various Wnt signaling components are enriched at centrosomes, we examined the functional contribution of centrosomes to Wnt signaling, β-catenin regulation, and posttranslational modifications. In HEK293 cells depleted of centrosomes we find that β-catenin synthesis and degradation rates are unaffected but that the normal accumulation of β-catenin in response to Wnt signaling is attenuated. This is due to accumulation of a novel high-molecular-weight form of phosphorylated β-catenin that is constitutively degraded in the absence of Wnt. Wnt signaling operates by inhibiting the destruction complex and thereby reducing destruction complex-phosphorylated β-catenin, but high-molecular-weight β-catenin is unexpectedly increased by Wnt signaling. Therefore these studies have identified a pool of β-catenin effectively shielded from regulation by Wnt. We present a model whereby centrosomes prevent inappropriate β-catenin modifications that antagonize normal stabilization by Wnt signals.

Identifiants

pubmed: 32583737
doi: 10.1091/mbc.E20-02-0139
pmc: PMC7525817
doi:

Substances chimiques

CTNNB1 protein, human 0
Transcription Factors 0
Wnt Proteins 0
beta Catenin 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1951-1961

Subventions

Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM114007
Pays : United States

Références

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1148-E1157
pubmed: 28137882
Nat Chem Biol. 2018 Jan;14(1):94-101
pubmed: 29083417
Cell Rep. 2019 Aug 20;28(8):1949-1960.e6
pubmed: 31433973
Nucleic Acids Res. 2009 Jan;37(Database issue):D175-80
pubmed: 18971254
Science. 2012 Dec 7;338(6112):1337-40
pubmed: 23138978
Biochim Biophys Acta. 2012 Oct;1823(10):1686-96
pubmed: 22705350
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6273-8
pubmed: 10339577
Trends Genet. 2011 Aug;27(8):307-15
pubmed: 21680046
Cancers (Basel). 2019 Jun 28;11(7):
pubmed: 31261718
J Cell Sci. 2016 Mar 1;129(5):983-93
pubmed: 26795562
Mol Cell. 2001 May;7(5):927-36
pubmed: 11389840
Dev Biol. 2011 Sep 1;357(1):259-68
pubmed: 21736876
Science. 2015 Apr 10;348(6231):1250834
pubmed: 25859050
Nat Cell Biol. 2011 Oct 03;13(10):1154-60
pubmed: 21968988
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3231-6
pubmed: 17296929
J Proteomics Bioinform. 2011;4(2):22-35
pubmed: 21720494
Science. 2015 Jun 5;348(6239):1155-60
pubmed: 25931445
J Biol Chem. 2004 Feb 6;279(6):4829-39
pubmed: 14594954
Curr Biol. 2015 Apr 20;25(8):1005-16
pubmed: 25819561
Dev Cell. 2009 Dec;17(6):788-99
pubmed: 20059949
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9304-9
pubmed: 27486244
Nat Rev Cancer. 2015 Nov;15(11):639-52
pubmed: 26493645
J Cell Sci. 2006 Nov 15;119(Pt 22):4702-9
pubmed: 17093267
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
Bioessays. 2013 Sep;35(9):804-9
pubmed: 23804296
Cell Cycle. 2016 Aug 17;15(16):2124-2134
pubmed: 27294844
Cell Rep. 2013 Jul 11;4(1):19-30
pubmed: 23831032
Cell. 2012 Jun 8;149(6):1245-56
pubmed: 22682247
Methods Mol Biol. 2014;1170:29-40
pubmed: 24906307
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5732-7
pubmed: 25901317
Mol Biol Cell. 2003 Jul;14(7):2844-60
pubmed: 12857869
J Cell Sci. 2014 Jun 15;127(Pt 12):2771-81
pubmed: 24762815
Development. 2007 Jul;134(14):2685-95
pubmed: 17567664
Nat Cell Biol. 2007 Feb;9(2):160-70
pubmed: 17330329
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7732-7
pubmed: 18511557
J Cell Sci. 2009 Oct 15;122(Pt 20):3791-8
pubmed: 19789178
Chem Biol. 2003 Dec;10(12):1255-66
pubmed: 14700633
Dev Cell. 2007 Jul;13(1):73-86
pubmed: 17609111
Results Probl Cell Differ. 2017;61:83-114
pubmed: 28409301
Curr Biol. 2003 Apr 15;13(8):680-5
pubmed: 12699626
FEBS Lett. 1999 Jun 25;453(3):249-53
pubmed: 10405154
EMBO J. 2012 Jun 13;31(12):2705-13
pubmed: 22617425
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10330-4
pubmed: 9294210
J Biol Chem. 2004 Mar 19;279(12):10829-32
pubmed: 14744872
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650):
pubmed: 25047618
Open Biol. 2014 Nov;4(11):140120
pubmed: 25392450
Science. 2013 May 17;340(6134):867-70
pubmed: 23579495
EMBO J. 2000 Jan 4;19(1):94-102
pubmed: 10619848
J Cell Sci. 2010 Sep 15;123(Pt 18):3125-35
pubmed: 20736306
Dev Cell. 2016 Sep 26;38(6):643-55
pubmed: 27676437
Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):E4639-47
pubmed: 27385826
Mol Biol Cell. 2014 Apr;25(7):977-91
pubmed: 24501426
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679

Auteurs

Setu M Vora (SM)

Department of Biology, University of Iowa, Iowa City, IA 52242-1324.

Jan S Fassler (JS)

Department of Biology, University of Iowa, Iowa City, IA 52242-1324.

Bryan T Phillips (BT)

Department of Biology, University of Iowa, Iowa City, IA 52242-1324.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH